Mountain Crest Acquisition Corp II Completes Business Combination with Better Therapeutics

Click Therapeutics Acquires Assets of Better Therapeutics, Inc.

May 22, 2024

Medical Devices

Click Therapeutics has acquired the assets of Better Therapeutics, Inc., including the FDA-authorized digital therapeutic AspyreRx (BT-001) and development candidates BT-002, BT-003 and BT-004. Click will integrate Better’s intellectual property into its AI-enabled platform to accelerate development of obesity and cardiometabolic digital therapeutics, optimizing programs for use alongside anti-obesity and diabetes medications.

Better Choice Company to Acquire SRx Health Solutions for Approximately $125 Million

September 3, 2024

Healthcare Services

Better Choice Company Inc. (NYSE American: BTTR) signed a definitive all-stock agreement to acquire SRx Health Solutions Inc. for approximately $125 million. The deal would combine Better Choice's pet health business (Halo) with SRx's Canadian specialty pharmacy network, creating a broader health and wellness company and unlocking operational synergies and geographic/vertical expansion.

Bristol Myers Squibb Acquires Turning Point Therapeutics

June 3, 2022

Biotechnology

Bristol Myers Squibb agreed to acquire clinical-stage precision oncology company Turning Point Therapeutics in an all-cash transaction valuing the company at approximately $4.1 billion ($76.00 per share). The deal adds Turning Point's lead asset, repotrectinib, and its precision oncology pipeline to BMS's oncology franchise and is expected to close in 2022 (tender offer completed and merger subsequently closed).

Catalent Acquires Bettera Brands from Highlander Partners for $1 Billion

August 30, 2021

Food & Beverage

Catalent, Inc. agreed to acquire Bettera Holdings, LLC (Bettera Brands) from Highlander Partners for $1 billion. The acquisition expands Catalent's consumer health and nutraceutical manufacturing capabilities—adding Bettera's gummy, soft chew, and lozenge production capacity and approximately 500 employees across four U.S. facilities.

BitBridge Capital Strategies Merges with Green Mountain Merger Inc. to Become Public

August 5, 2025

Financial Services

BitBridge Capital Strategies completed a merger with Green Mountain Merger Inc., enabling BitBridge to begin trading on the OTC market under the ticker BTTL and pursue an eventual NASDAQ uplisting. The transaction positions BitBridge as a pure-play Bitcoin treasury company focused on accumulating Bitcoin reserves and launching consumer-facing Bitcoin lending products.

BioPharmX Corp to Merge with Timber Pharmaceuticals

January 28, 2020

Pharmaceuticals

BioPharmX Corporation (NYSE American: BPMX) entered into a definitive merger agreement with Timber Pharmaceuticals LLC whereby a BioPharmX subsidiary will merge into Timber, leaving Timber as a wholly‑owned subsidiary of BioPharmX. The transaction will bring at least $20 million of financing to the combined company, after which BioPharmX will change its name to Timber Pharmaceuticals and Timber’s management will become the combined company's leadership.